Metastatic Prostate Cancer Treatment Guidelines
For instance breast cancer that has spread to the lungs is called metastatic breast cancer to the lungs it s not lung cancer.
Metastatic prostate cancer treatment guidelines. A rise in psa in prostate cancer patients after treatment with surgery or radiation psa of 0 2ng ml and a confirmatory value of 0 2ng ml or greater following radical prostatectomy and nadir 2 0ng ml following radiation. With these patients in mind guideline statements were developed to provide a rational basis for. The proportion of pca cases that are metastatic at diagnosis ranges globally from 5 20 in countries with widespread screening practices to upward of 30 60 where. The portions of the guidelines included herein focus on the roles of germline and somatic genetic testing risk stratification with nomograms and tumor multigene molecular testing androgen deprivation therapy secondary hormonal therapy chemotherapy and immunotherapy in patients with prostate cancer.
In the treatment of metastatic prostate cancer one chemotherapy drug is usually given rather than multiple drugs being given in combination. Treatment includes adt or radiation therapy doses of 78 80 gy with 3d crt imrt with igrt plus long term neoadjuvant concomitant. Apalutamide can also be used for metastatic castrate sensitive prostate cancer. Since 1944 when huggins and hodges demonstrated the effectiveness of bilateral orchiectomy for metastatic prostate cancer pca androgen deprivation therapy adt has been the first line treatment for men with advanced pca.
Some of the drugs used are docetaxel taxotere cabazitaxel jevtana mitoxantrone novantrone and estramustine emyct. Register for a free account then click on the cancer types below to display a drop down of options. Mri and biopsy localised and locally advanced prostate cancer follow up for localised or locally advanced prostate cancer treatment for metastatic prostate cancer bone targeted therapies. Treatment is also based on where the cancer started.
This may occur in patients who do not have symptoms hormone sensitive prostate cancer prostate cancer that has either not. To assist in clinical decision making six index patients were developed representing the most common clinical scenarios that are encountered in clinical practice. This guideline includes new and updated recommendations on. If prostate cancer spreads to the bones it s still prostate cancer not bone cancer and the doctor will recommend treatments that have been shown to.
Clinicians are challenged with a multitude of treatment options for patients with castration resistant prostate cancer crpc. The nccn guidelines are free.